Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Prince

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCCPaul L Swiecicki, Emily Bellile, Aleksandar F Dragovic, et al.
Clinical and Translational Radiation Oncology|January 13, 2022
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trialsLaila A Gharzai, Julia Pakela, Elizabeth M Jaworski, et al.
Head & Neck|February 26, 2017
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell linesHeather M Walline, Christine M Goudsmit, Jonathan B McHugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 21, 2020
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapyMolly E Heft Neal, Julia Brennan, Catherine T Haring, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2018
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinomaJacqueline E Mann, Joshua D Smith, Andrew C Birkeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell CarcinomaYue Cao, Catherine T Haring, Collin Brummel, et al.
The Laryngoscope|June 9, 2009
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasionFrancis P Worden, Jeffrey Moyer, Julia S Lee, et al.
OTO Open|June 18, 2026
Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term SurveillancePrarthana J Dalal, Sarah M Dermody, Haadi Ali, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCCPaul L Swiecicki, Emily Bellile, Aleksandar F Dragovic, et al.
Clinical and Translational Radiation Oncology|January 13, 2022
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trialsLaila A Gharzai, Julia Pakela, Elizabeth M Jaworski, et al.
Head & Neck|February 26, 2017
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell linesHeather M Walline, Christine M Goudsmit, Jonathan B McHugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 21, 2020
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapyMolly E Heft Neal, Julia Brennan, Catherine T Haring, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2018
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinomaJacqueline E Mann, Joshua D Smith, Andrew C Birkeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell CarcinomaYue Cao, Catherine T Haring, Collin Brummel, et al.
The Laryngoscope|June 9, 2009
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasionFrancis P Worden, Jeffrey Moyer, Julia S Lee, et al.
OTO Open|June 18, 2026
Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term SurveillancePrarthana J Dalal, Sarah M Dermody, Haadi Ali, et al.
Pageof 13